Despite the many advances in cardiovascular medicine, decisions concerning the
diagnosis, prevention, and treatment of left ventricular (LV) thrombus often remain …

Aims Left ventricular thrombus (LVT) increases the risk of thrombotic events and mortality.
Vitamin K antagonists (VKAs) used to treat LVT have several known risks, as a result of …

The management of myocardial ischemia/reperfusion (I/R) damage in the context of
reperfusion treatment remains a significant hurdle in the field of cardiovascular disorders …

Myocardial infarction (MI) results in cardiomyocyte necrosis and conductive system damage,
leading to sudden cardiac death and heart failure. Studies have shown that conductive …

Cardioembolic stroke, a subtype of ischemic stroke with the worst prognosis, is quietly
threatening public health. We aimed to visualize the development trend and hotspots of …

Heart failure (HF) is a clinical syndrome that is divided into 3 subtypes based on the left
ventricular ejection fraction. Every subtype has specific clinical characteristics and …

Abstract Aims Direct oral anticoagulants (DOACs) are increasingly used off-label to treat
patients with left ventricular thrombus (LVT). We analysed available meta-data comparing …

There is insufficient data on systemic embolic events (SSEs) in patients with ischemic left
ventricular aneurysm (LVA) concerning the impact of anticoagulation therapy. In this …

Aims A left ventricular thrombus (LVT) is not uncommon in patients with impaired LV systolic
function. However, the treatment strategy for LVT has not yet been fully established. We …

Takotsubo syndrome: unravelling the enigma of the broken heart syndrome?—a narrative
review - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …